Results 141 to 150 of about 21,372 (208)

Simultaneous quantification of venetoclax, selinexor, voriconazole and fluconazole in human plasma by HPLC-MS/MS and its application in hematological malignancies. [PDF]

Front Pharmacol
Han F, Wang Y, Jian Y, Hu T, Zhu Y, Ding X, Zhang J, Wei R, Zhu H, An Z.   +9 more
europepmc   +1 more source

CD84 expression stratifies venetoclax response and reveals a targetable vulnerability in resistant acute myeloid leukemia. [PDF]

Exp Hematol Oncol
Wang X, Lin X, Chen T, Chen Y, Wang H, Zhu Y.   +5 more
europepmc   +1 more source

Hodgkin Reed–Sternberg‐Like Cells in T‐Cell/Histiocyte‐Rich Large B‐Cell Lymphoma

eJHaem, Volume 7, Issue 5, October 2026.
Ulysses Mustaki, Stephen Lade, Mary Ann Anderson, Kah Lok Chan   +3 more
wiley   +1 more source

Melatonin potentiates the antineoplastic effects of venetoclax in acute myeloid leukemia cells. [PDF]

Hematol Transfus Cell Ther
Vahedian V, Lima K, de Almeida BO, Cavaglieri RC, Machado-Neto JA, Rego EM.   +5 more
europepmc   +1 more source

Venetoclax for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: Prospects, resistance mechanisms and management strategies. [PDF]

Clin Transl Med
Zhang J, Liu J, Zhao M, Zhang X, Liu L, Li M, Cao C, Zhang R, Zhao M.   +8 more
europepmc   +1 more source

Giant cellulitis‐like Sweet's syndrome induced by gilteritinib

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page e1472-e1474, October 2026.
Juan de Luque‐Fernández, Irene Rivera‐Ruiz, Irene Suárez‐Vergne, Inmaculada Sánchez‐Ramírez, Manuel Galán‐Gutiérrez, Antonio José Vélez García‐Nieto   +5 more
wiley   +1 more source

Safe Accelerated Venetoclax Escalation: a phase 1b study of obinutuzumab plus venetoclax with daily ramp-up in CLL. [PDF]

Blood Adv
Crombie JL, Ahn IE, Ren Y, Tyekucheva S, Carey C, Kniezewski M, Normilus S, Solomon S, Montegaard J, Kim AI, Merryman RW, Armand P, Fisher DC, Brown JR, Davids MS.   +14 more
europepmc   +1 more source

AI-enabled multi-omics pharmacogenomic modeling guides resistance-aware multitarget optimization of venetoclax therapy in acute myeloid leukemia. [PDF]

NPJ Precis Oncol
Wang C, You Z, Chen S, He Y, Chen X, Qu S, Chen X, Jiang S.   +7 more
europepmc   +1 more source

Defining a Therapeutic Window for Venetoclax in Post-Transplant Maintenance Therapy for High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes. [PDF]

Hematol Oncol
Lyu C, Xie T, Pu Y, Luan X, Xiao X, Zhao M, Lyu H.   +6 more
europepmc   +1 more source

Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience. [PDF]

Hematol Oncol
Ballotta L, Olivieri J, Facchinelli D, Ferrarini I, Visentin A, Moia R, Cavallari M, Innao V, Derenzini E, Nierychlewska PM, Cuda A, Gattei V, Ballerini M, Lucchini E, Turoldo M, Rossetti MC, Gaudio F, Zaja F.   +17 more
europepmc   +1 more source